These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 6989693)
1. The crux of the UGDP. Spurious results and biologically inappropriate data analysis. Kilo C; Miller JP; Williamson JR Diabetologia; 1980 Mar; 18(3):179-85. PubMed ID: 6989693 [No Abstract] [Full Text] [Related]
2. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results. Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344 [No Abstract] [Full Text] [Related]
3. A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP). Seltzer HS Diabetes; 1972 Sep; 21(9):976-9. PubMed ID: 5055722 [No Abstract] [Full Text] [Related]
5. Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents. JAMA; 1975 Feb; 231(6):583-608. PubMed ID: 1089822 [No Abstract] [Full Text] [Related]
6. Comments on the UGDP study. Schöffling K Horm Metab Res; 1974; Suppl 4():188-91. PubMed ID: 4608018 [No Abstract] [Full Text] [Related]
7. The influence of diagnostic criteria on the mortality findings in the University Group Diabetic Programme study of diabetic therapy. Gray RH Med J Aust; 1973 Mar; 1(12):594-6. PubMed ID: 4573383 [No Abstract] [Full Text] [Related]
8. The UGDP--tolbutamide and mortality. Knowles HC Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432 [No Abstract] [Full Text] [Related]
9. A prospective view of the treatment of adult-onset diabetes with special reference to the University Group Diabetes Program and oral hypoglycemic agents. Prout TE Med Clin North Am; 1971 Jul; 55(4):1065-75. PubMed ID: 4946757 [No Abstract] [Full Text] [Related]
10. The University Group Diabetes Program. A further statistical analysis of the mortality findings. Cornfield J JAMA; 1971 Sep; 217(12):1676-87. PubMed ID: 4937386 [No Abstract] [Full Text] [Related]
12. Editorials: Statistical problems in clinical trials: the UGDP study revisited. Schor SS Am J Med; 1973 Dec; 55(6):727-32. PubMed ID: 4584989 [No Abstract] [Full Text] [Related]
13. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report. Diabetes; 1982 Nov; 31 Suppl 5():1-81. PubMed ID: 6757026 [No Abstract] [Full Text] [Related]
14. Farewell to phenformin for treating diabetes mellitus. Williams RH; Palmer JP Ann Intern Med; 1975 Oct; 83(4):567-8. PubMed ID: 1166991 [No Abstract] [Full Text] [Related]
15. Diabetes in the elderly patient. Shagan BP Med Clin North Am; 1976; 60(6):1191-208. PubMed ID: 790046 [No Abstract] [Full Text] [Related]
16. Therapy of type 2 diabetes, cardiovascular death, and the UGDP. Feinglos MN; Bethel MA Am Heart J; 1999 Nov; 138(5 Pt 1):S346-52. PubMed ID: 10539796 [No Abstract] [Full Text] [Related]
17. [Increased risk of cardiovascular complications with oral hypoglycemic agents?]. Mueller R Acta Diabetol Lat; 1970; 7(5):805-23. PubMed ID: 4949515 [No Abstract] [Full Text] [Related]
18. The University Group Diabetes Program. A statistician looks at the mortality results. Schor S JAMA; 1971 Sep; 217(12):1671-5. PubMed ID: 4937385 [No Abstract] [Full Text] [Related]
20. [The venture of University Group Diabetes Program (UGDP). Some personal reflexions. Tolbutamide and phenformin under accusation]. Pirart J Nouv Presse Med; 1972 Jan; 1(5):325-8. PubMed ID: 5010448 [No Abstract] [Full Text] [Related] [Next] [New Search]